DNA methylation in inflammatory genes among children with obstructive sleep apnea

American Journal of Respiratory and Critical Care Medicine

Volumn 185, Issue 3, 2012, Pages 330-338

  Kim, Jinkwan ^a   Bhattacharjee, Rakesh ^a   Khalyfa, Abdelnaby ^a   Kheirandish Gozal, Leila ^a   Capdevila, Oscar Sans ^a   Wang, Yang ^a   Gozal, David ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

DNA methylation; Epigenetics; Inflammation; Obstructive sleep apnea; T regulatory lymphocytes

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; INTERFERON REGULATORY FACTOR 1; TRANSCRIPTION FACTOR FOXP3;

APNEA; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; HUMAN; INFLAMMATION; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SLEEP APNEA SYNDROME;

C-REACTIVE PROTEIN; CALGRANULIN A; CALGRANULIN B; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC MARKERS; HUMANS; INFLAMMATION; LINEAR MODELS; LIPIDS; MALE; MULTIVARIATE ANALYSIS; POLYSOMNOGRAPHY; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SLEEP APNEA, OBSTRUCTIVE;

EID: 84863012875     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201106-1026OC     Document Type: Article

References (67)

1. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006;113:898-918.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among us adults, 1999-2008. JAMA 2010;303:235-241.
3. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis 2009;51:434-451.
4. Gozal D, Kheirandish-Gozal L, Bhattacharjee R, Spruyt K. Neuro-cognitive and endothelial dysfunction in children with obstructive sleep apnea. Pediatrics 2010;126:e1161-e1167.
5. Gozal D, Crabtree VM, Sans Capdevila O, Witcher LA, Kheirandish- Gozal L. C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med 2007;176:188-193. (Pubitemid 47057856)
6. Gozal D. Sleep, sleep disorders and inflammation in children. Sleep Med 2009;10:S12-S16.
7. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in osahs: the oxidative stress link. Eur Respir J 2009;33:1467-1484.
8. Ryan S, Taylor CT, McNicholas WT. Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome? Thorax 2009;64:631-636.
9. Tam CS, Wong M, McBain R, Bailey S, Waters KA. Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health 2006;42:277-282. (Pubitemid 43736365)
10. Kaditis AG, Alexopoulos EI, Kalampouka E, Kostadima E, Germenis A, Zintzaras E, Gourgoulianis K. Morning levels of c-reactive protein in children with obstructive sleep-disordered breathing. Am J Respir Crit Care Med 2005;171:282-286.
11. Kent BD, Ryan S, McNicholas WT. The genetics of obstructive sleep apnoea. Curr Opin Pulm Med 2010;16:536-542.
12. Kim J, Hakim F, Kheirandish-Gozal L, Gozal D. Inflammatory pathways in children with insufficient or disordered sleep. Respir Physiol Neurobiol 2011;178:465-474.
13. Bhattacharjee R, Kim J, Kheirandish-Gozal L, Gozal D. Obesity and obstructive sleep apnea syndrome in children: a tale of inflammatory cascades. Pediatr Pulmonol 2010;46:313-323.
14. Rammes A, Roth J, Goebeler M, Klempt M, Hartmann M, Sorg C. Myeloid-related protein (mrp) 8 and mrp14, calcium-binding proteins of the s100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem 1997;272:9496-9502. (Pubitemid 27154966)
15. Guignard F, Mauel J, Markert M. Phosphorylation of myeloid-related proteins mrp-14 and mrp-8 during human neutrophil activation. Eur J Biochem 1996;241:265-271. (Pubitemid 26342998)
16. Croce K, Gao H, Wang Y, Mooroka T, Sakuma M, Shi C, Sukhova GK, Packard RR, Hogg N, Libby P, et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation 2009; 120:427-436.
17. Healy AM, Pickard MD, Pradhan AD, Wang Y, Chen Z, Croce K, Sakuma M, Shi C, Zago AC, Garasic J, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006;113:2278-2284. (Pubitemid 43947973)
18. Kim J, Bhattacharjee R, Snow AB, Capdevila OS, Kheirandish-Gozal L, Gozal D. Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea. Eur Respir J 2010;35:843-850.
19. Ordovas JM, Smith CE. Epigenetics and cardiovascular disease. Nat Rev Cardiol 2010;7:510-519.
20. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, Schubeler D. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007;39:457-466. (Pubitemid 46514772)
21. Brigati C, Banelli B, di Vinci A, Casciano I, Allemanni G, Forlani A, Borzi L, Romani M. Inflammation, HIF-1, and the epigenetics that follows. Mediators Inflamm 2010;2010:263914.
22. Delcuve GP, Rastegar M, Davie JR. Epigenetic control. J Cell Physiol 2009;219:243-250.
23. Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 2009;58:2718-2725.
24. Campion J, Milagro FI, Martinez JA. Individuality and epigenetics in obesity. Obes Rev 2009;10:383-392.
25. Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, Hwa YL, Li J, Dowdy SC, Jiang SW. DNA hypermethylation as a chemotherapy target. Cell Signal 2010;23:1082-1093.
26. Yang IV, Schwartz DA. Epigenetic control of gene expression in the lung. Am J Respir Crit Care Med 2010;183:1295-1301.
27. American Thoracic Society. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 1996;153: 866-878.
28. Montgomery-Downs HE, O'Brien LM, Gulliver TE, Gozal D. Polysomnographic characteristics in normal preschool and early schoolaged children. Pediatrics 2006;117:741-753. (Pubitemid 46063216)
29. Iber C, Ancoli-Israel S, Chesson AL, Quan SF. The AASM manual for the scoring of sleep and associated events. Westchester IL: American Academy of Sleep Medicine; 2007.
30. Rechstschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles, CA: Brain Information Services/Brain Research Institute; 1968.
31. Schulz H. Phasic or transient? Comment on the terminology of the aasm manual for the scoring of sleep and associated events. J Clin Sleep Med 2007;3:752. (Pubitemid 351204507)
32. American Sleep Disorders Association. EEG arousals: scoring rules and examples: a preliminary report from the sleep disorders atlas task force of the American Sleep Disorders Association. Sleep 1992;15:173-184.
33. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114:555-576.
34. Ordway JM, Bedell JA, Citek RW, Nunberg A, Garrido A, Kendall R, Stevens JR, Cao D, Doerge RW, Korshunova Y, et al. Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets. Carcinogenesis 2006;27:2409-2423. (Pubitemid 44884098)
35. Jaspers I, Horvath KM, Zhang W, Brighton LE, Carson JL, Noah TL. Reduced expression of irf7 in nasal epithelial cells from smokers after infection with influenza. Am J Respir Cell Mol Biol 2010;43:368-375.
36. Mikeska T, Felsberg J, Hewitt CA, Dobrovic A. Analysing DNA methylation using bisulphite pyrosequencing. Methods Mol Biol 2011;791:33-53.
37. Wieczorek G, Asemissen A, Model F, Turbachova I, Floess S, Liebenberg V, Baron U, Stauch D, Kotsch K, Pratschke J, et al. Quantitative DNA methylation analysis of foxp3 as a new method for counting regulatory t cells in peripheral blood and solid tissue. Cancer Res 2009;69:599-608.
38. Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, Thiel A, Boeld TJ, Hoffmann P, Edinger M, et al. DNA demethylation in the human foxp3 locus discriminates regulatory t cells from activated foxp3(1) conventional t cells. Eur J Immunol 2007;37:2378-2389. (Pubitemid 47423608)
39. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (monitoring trends and determinants in cardiovascular disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999;99:237-242. (Pubitemid 29056365)
40. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P. Statin therapy, LDL cholesterol, c-reactive protein, and coronary artery disease.NEngl J Med 2005;352:29-38. (Pubitemid 40075678)
41. Pasceri V, Cheng JS, Willerson JT, Yeh ET. Modulation of c-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 2001;103:2531-2534. (Pubitemid 32521959)
42. Can M, Acikgoz S, Mungan G, Bayraktaroglu T, Kocak E, Guven B, Demirtas S. Serumcardiovascular risk factors in obstructive sleep apnea. Chest 2006;129:233-237. (Pubitemid 43289839)
43. Kageyama N, Nomura M, Nakaya Y, Watanabe T, Ito S. Relationship between adhesion molecules with hs-crp and changes therein after arb (valsartan) administration in patients with obstructive sleep apnea syndrome. J Med Invest 2006;53:134-139.
44. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M. Elevated levels of c-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-1134. (Pubitemid 36297204)
45. Tauman R, Ivanenko A, O'Brien LM, Gozal D. Plasma c-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004;113:e564-e569.
46. Li AM, Chan MH, Yin J, So HK, Ng SK, Chan IH, Lam CW, Wing YK, Ng PC. C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol 2008;43:34-40.
47. Kheirandish-Gozal L, Capdevila OS, Tauman R, Gozal D. Plasma c-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med 2006;2:301-304. (Pubitemid 44299553)
48. Goldbart AD, Levitas A, Greenberg-Dotan S, Ben Shimol S, Broides A, Puterman M, Tal A. B-type natriuretic peptide and cardiovascular function in young children with obstructive sleep apnea. Chest 2010;138:528-535.
49. Barcelo A, Barbe F, Llompart E, Mayoralas LR, Ladaria A, Bosch M, Agusti AG. Effects of obesity on c-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea. Am J Med 2004;117:118-121. (Pubitemid 38953732)
50. Guilleminault C, Kirisoglu C, Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep 2004;27:1507-1511. (Pubitemid 40041619)
51. Dyugovskaya L, Lavie P, Hirsh M, Lavie L. Activated cd8+ t-lymphocytes in obstructive sleep apnoea. Eur Respir J 2005;25:820-828. (Pubitemid 40667679)
52. Lavie L, Dyugovskaya L, Polyakov A. Biology of peripheral blood cells in obstructive sleep apnea - the tip of the iceberg. Arch Physiol Biochem 2008;114:244-254.
53. Gozal D, Serpero LD, Sans Capdevila O, Kheirandish-Gozal L. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med 2008;9:254-259. (Pubitemid 351387097)
54. Rudensky AY. Regulatory t cells and foxp3. Immunol Rev 2011;241:260-268.
55. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory t cell development and the forkhead family transcription factor foxp3. Nat Immunol 2005;6:331-337. (Pubitemid 41716769)
56. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory t cells and immune tolerance. Cell 2008;133:775-787. (Pubitemid 351707693)
57. Huehn J, Polansky JK, Hamann A. Epigenetic control of foxp3 expression: the key to a stable regulatory t-cell lineage? Nat Rev Immunol 2009;9:83-89.
58. Gluckman PD, Hanson MA, Buklijas T, Low FM, Beedle AS. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol 2009;5:401-408.
59. Wilson CB, Rowell E, Sekimata M. Epigenetic control of t-helper-cell differentiation. Nat Rev Immunol 2009;9:91-105.
60. Liu J, Lluis A, Illi S, Layland L, Olek S, von Mutius E, Schaub B. T regulatory cells in cord blood-foxp3 demethylation as reliable quantitative marker. PLoS ONE 2010;5:e13267.
61. Yang JY, Hung MC. Deciphering the role of forkhead transcription factors in cancer therapy. Curr Drug Targets 2011;12:1284-1290.
62. Watson JA, Watson CJ, McCann A, Baugh J. Epigenetics, the epicenter of the hypoxic response. Epigenetics 2010;5:293-296.
63. Lee JS, Kim Y, Kim IS, Kim B, Choi HJ, Lee JM, Shin HJ, Kim JH, Kim JY, Seo SB, et al. Negative regulation of hypoxic responses via induced reptin methylation. Mol Cell 2010;39:71-85.
64. Tausendschon M, Dehne N, Brune B. Hypoxia causes epigenetic gene regulation in macrophages by attenuating jumonji histone demethylase activity. Cytokine 2011;53:256-262.
65. Mimura I, Tanaka T, Wada Y, Kodama T, Nangaku M. Pathophysiological response to hypoxia: from the molecular mechanisms of malady to drug discovery: epigenetic regulation of the hypoxic response via hypoxia-inducible factor and histone modifying enzymes. J Pharmacol Sci 2011;115:453-458.
66. Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, Heimburger O, Barany P, Alvestrand A, Nordfors L, et al. Impact of inflammation on epigenetic DNA methylation: a novel risk factor for cardiovascular disease? J Intern Med 2007;261:488-499. (Pubitemid 46587721)
67. DeAngelis JT, FarringtonWJ, Tollefsbol TO. An overview of epigenetic assays. Mol Biotechnol 2008;38:179-183.